Actos Now for Prevention of Diabetes (ACT NOW)

PHASE3CompletedINTERVENTIONAL
Enrollment

602

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Impaired Glucose ToleranceType 2 Diabetes
Interventions
DRUG

Pioglitazone

Pioglitazone tablets - 45 mg/day

DRUG

Placebo

Placebo tablets similar to pioglitazone tablets - 1 tablet/day

Trial Locations (8)

11203

SUNY Health Science Center, Brooklyn

20007

Georgetown University, Washington D.C.

38163

University of Tennessee, Memphis

70808

Pennington Biomedical Research Center, Baton Rouge

78207

Texas Diabetes Institute, San Antonio

85012

Carl T. Hayden VA Medical Center, Phoenix

90033

USC-Keck School of Medicine, Los Angeles

92161

University of California San Diego-San Diego VA Medical Center, San Diego

All Listed Sponsors
collaborator

University of Texas

OTHER

collaborator

Takeda Pharmaceuticals North America, Inc.

INDUSTRY

lead

The University of Texas Health Science Center at San Antonio

OTHER

NCT00220961 - Actos Now for Prevention of Diabetes (ACT NOW) | Biotech Hunter | Biotech Hunter